4//SEC Filing
Crowley Elizabeth 4
Accession 0001415889-24-017362
CIK 0000744218other
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 4:04 PM ET
Size
9.1 KB
Accession
0001415889-24-017362
Insider Transaction Report
Form 4
Crowley Elizabeth
SR. VP & CPDO
Transactions
- Sale
Common Stock
2024-06-14$34.87/sh−30,000$1,045,962→ 9,074 total - Exercise/Conversion
Incentive Stock Option (Right to Buy)
2024-06-14−30,000→ 46,500 totalExercise: $10.38Exp: 2030-06-18→ Common Stock (30,000 underlying) - Exercise/Conversion
Common Stock
2024-06-14$10.38/sh+30,000$311,400→ 39,074 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.51 to $35.39 per share, inclusive. The reporting person undertakes to provide to Celldex Therapeutics, Inc., any security holder of Celldex Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- [F2]As of June 18, 2024, the option is fully vested.
Documents
Issuer
Celldex Therapeutics, Inc.
CIK 0000744218
Entity typeother
Related Parties
1- filerCIK 0001681854
Filing Metadata
- Form type
- 4
- Filed
- Jun 17, 8:00 PM ET
- Accepted
- Jun 18, 4:04 PM ET
- Size
- 9.1 KB